PRODUCT DETAILS VIEW ALL PRODUCTS

Coverit topical solution (Minoxidil)

  • Minoxidil 2% / 5% / 10% Topical Solution
  • Indicated in treatment of alopecia (male pattern baldness) in men.
  • Minoxidil enhances microcirculation to hair follicles, Growth Factor (VEGF) is stimulated by minoxidil and VEGF is presumably responsible for the increased capillary fenestration, indicative of a high metabolic activity, observed during the anagen phase
  • A total dose of 1 mL should be applied twice per day to the scalp, beginning at the centre of the affected area. This dose should be used regardless of the size of the affected area.
  • Patients with a history of sensitivity to minoxidil, ethanol, or propylene glycol, treated or untreated hypertension, any scalp abnormality, shaved scalp, if occlusive dressings or other topical medical preparations are being used.
  • Should not be applied to inflamed, infected, irritated or painful scalp skin., indicated for the treatment of alopecia androgenetica and hair loss is sudden and/or patchy, or the reason for hair loss is unknown. Inhalation of the spray mist should be avoided. Minoxidil contains propylene glycol, which may cause skin irritation.
  • Pregnancy category C. Should not be used by pregnant women. Not to be used by nursing women. Safety and efficacy in pediatric patients have not been established.
  • Minoxidil should not be used concomitantly with other medications applied topically on the scalp. Corticosteroids has been shown to increase local tissue concentrations, Topical drugs, such as corticosteroids, tretinoin, dithranol or petrolatum, which alter the stratum corneum barrier, could result in increased absorption of minoxidil.
  • The most common adverse reactions are hypersensitivity reactions, headache, colds and respiratory infections. Dermatological adverse reactions include scaling, itching and rash.
  • Dermatologicals and Cosmetologicals